Who we are

LTN-Pharm Pharmaceutical Company was founded in 2010 in St Petersburg and is one of few domestic enterprises of this branch, which is engaged in development and registration of proprietary and innovative medicinal drugs. The analysis of problems of modern medicine has led the company’s scientists to comprehension of the necessity of development of new antifungal drugs. Treatment of diseases caused by fungi is of current importance for all countries. The number of patients with various forms of mycoses does not show a tendency for a decrease, because mycotic infections are poorly curable, which is due to both the insufficient efficiency of available medicinal drugs and the quick mutability of microorganisms, leading to appearance of stable forms. A serious challenge is mycoses occurring as a result of socially significant diseases such as AIDS, tuberculosis, malignant neoplasms, treatment of patients after transplantation of organs and tissues, especially the bone marrow. In the therapy of mycotic infections, there is plenty of unsolved problems:
  • Low efficiency of available drugs towards fungi being part of biofilms
  • Propagation of strains resistant to available drugs
  • Lack of new drugs with the fungicidal effect
  • Low efficiency of available drugs towards agents of extremely dangerous subcutaneous mycoses
  • Insufficient efficiency of treatment of patients with immunodeficiency (AIDS, oncology, diabetes mellitus, patients after transplantation of organs (in particular the bone marrow etc.)
  • Insufficient efficiency of treatment of cryptococcal meningitides and pneumonia (included in the FDA, EMA list of extremely important infections)
  • Insufficient efficiency of treatment of pulmonary aspergillosis (included in the FDA, EMA list of extremely important infections)
Low efficiency of therapy of onychomycoses   The first medicinal drug to have been created by LTN-Pharm Company is an innovative antifungal drug intended for treatment of variously localized infections. The drug is originally structured and has a wide range of action towards various fungi with the fungicidal effect (kills microorganisms). Our team consists of highly qualified professionals with wide experience in development of new synthetic medicinal drugs, their clinical tests and introduction into medical practice. LTN-Pharm Company widely cooperates with medical centers and pharmaceutical companies both in Russia and abroad, following modern trends in world public health protection.